Disitamab vedotin (RC-48) is a HER2-targeting antibody-drug conjugate (ADC) that delivers the cytotoxic agent MMAE. It demonstrates potent anti-tumor activity in vitro and in vivo against gastric cancer models with varying HER2 expression, inhibiting proliferation and downregulating HER2 protein levels.
Concentration:
20.6 mg/mL
Molecular Weight:
Approximately 144.15 kDa
Purity:
98.00% (May vary between batches)
CAS Number:
[2136633-23-1]
Target:
EGFR,Antibody-Drug Conjugates (ADCs)
* VAT and and shipping costs not included. Errors and price changes excepted
